Aspyra Inc
OTC:APYI

Watchlist Manager
Aspyra Inc Logo
Aspyra Inc
OTC:APYI
Watchlist
Price: 0.0002 USD Market Closed
Market Cap: 10k USD

EV/EBITDA
Enterprise Value to EBITDA

-1.1
Current
-1.1
Median
11.5
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-1.1
=
Enterprise Value
3.9m USD
/
EBITDA
-3.6m USD
EBITDA Growth EV/EBITDA to Growth
US
Aspyra Inc
OTC:APYI
Average EV/EBITDA: 1 416.7
Negative Multiple: -1.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
49.4
38%
1.3
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
208.6
38%
5.5
MY
U
Ucrest Bhd
KLSE:UCREST
12 216.4
N/A N/A
US
Doximity Inc
NYSE:DOCS
44.1
21%
2.1
JP
M3 Inc
TSE:2413
19
13%
1.5
US
W
Waystar Holding Corp
NASDAQ:WAY
23.8
18%
1.3
SE
Sectra AB
STO:SECT B
Negative Multiple: -145 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
60.3
90%
0.7
CN
Winning Health Technology Group Co Ltd
SZSE:300253
106.4
48%
2.2

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A